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ABBREVIATIONS  
COPSAC2000 = COpenhagen Prospective Studies on Asthma in Childhood 
CXCL8  = Chemokine (C-X-C motif) ligand 8 
hs-CRP = high-sensitivity C-reactive protein 
IL-1β = Interleukin-1β 
IL-6 = Interleukin-6 
NCD = non communicable disease 
TNF-α = tumor necrosis factor-α 
PCA = principle component analysis 
 
ABSTRACT (248 words) 
Background 
Systemic low-grade inflammation has been demonstrated in a range of the frequent 
noncommunicable diseases (NCDs) proposing a shared mechanism, but is largely 
unexplored in relation to allergic sensitization. We therefore aimed to investigate the 
possible association with childhood allergic sensitization. 
Methods  
High sensitivity C-reactive protein (hs-CRP), interleukin-1β (IL-1β), IL-6, tumor necrosis 
factor-α (TNF-α) and chemokine (C-X-C motif) ligand 8 (CXCL8) were measured in 
plasma at age 6mo (N=214) and 7yrs (N=277) in children from the Copenhagen 
Prospective Studies on Asthma in Childhood2000 (COPSAC2000) birth cohort. Allergic 
sensitization against common inhalant and food allergens was determined 
longitudinally at age ½, 1½, 4 and 6yrs by specific-IgE assessments and skin prick tests. 
Associations between inflammatory biomarkers and sensitization phenotypes were 
tested with logistic regression and principle component analyses (PCA).  
Results 
Adjusted for gender, recent infections and a CRP genetic risk-score, hs-CRP at 7yrs was 
associated with concurrent elevated specific-IgE against any allergen (adjusted OR 
(aOR) =1.40; 95% CI, 1.14-1.72; p=0.001), aeroallergens (aOR, 1.43; 1.15-1.77; p=0.001), 
food allergens (aOR, 1.31; 95% CI, 1.02-1.67; p=0.04), sensitization without any clinical 
allergy symptoms (aOR=1.40; 1.06-1.85; p=0.02), and with similar findings for skin 
prick tests. The other inflammatory markers were not univariantly associated with 
sensitization, but multi-parametric PCA suggested a specific inflammatory response 
among sensitized children. Inflammatory markers at age 6mo were not associated with 
subsequent development of sensitization phenotypes. 
Conclusions 
Elevated hs-CRP is associated with allergic sensitization in school-aged children 
suggesting systemic low-grade inflammation as a phenotypic characteristic of this early 
onset NCD. 
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INTRODUCTION 
Chronic noncommunicable diseases (NCDs) encompass cardiovascular diseases, 
metabolic diseases, cancer, and chronic lung diseases. The earliest debuting NCDs are 
childhood asthma and allergy (1) and while asthma is usually considered part of chronic 
lung diseases, childhood allergy is vastly neglected in NCD research.  
The growing burden of NCDs is a major global health threat (2) but despite decades of 
intensive research identifying preventive measures has largely failed, which may be due 
to a far too disease-specific approach rather than exploring common features and 
mechanisms in the origins of NCDs. Recent findings pinpoint that chronic low-grade 
inflammation is a common nominator of virtually all NCDs (3), which is reflected by 
elevated levels of C-reactive protein measured by high-sensitivity assays (hs-CRP) in 
highly endemic societies (4) and accompanying the specific disorders like 
cardiovascular disease (5), diabetes mellitus (6), chronic obstructive pulmonary disease 
(7) and asthma (8). However, only very few studies have investigated whether 
childhood allergic sensitization is also characterized by systemic low-grade 
inflammation. 
The objective of this work was therefore to investigate whether a systemic low-grade 
inflammatory process is present in young children with allergic sensitization based on 
data from the Copenhagen Prospective Studies on Asthma in Childhood2000 (COPSAC2000) 
birth cohort (9). For that purpose, we measured plasma levels of hs-CRP along with 
secondary assessments of related inflammatory biomarkers including interleukin 6 (IL-
6), IL-1β, tumor necrosis factor (TNF)-α and chemokine (C-X-C motif) ligand 8 (CXCL8, 
formerly IL-8) at age 6 months and 7 years and investigated the possible association 
with allergic sensitization and rhinitis during pre-school age.   
 
METHODS 
The COPSAC2000 Birth Cohort 
The participants comprised 411 children of the at-risk COPSAC2000 prospective birth 
cohort study born to mothers with physician-diagnosed asthma (9). The children were 
enrolled at age 4 weeks and subsequently attended the COPSAC single-center clinical 
research unit for scheduled clinical investigations at 6-monthly intervals until age 7 
years as well as immediately upon onset of any respiratory-, allergy- or skin-related 
symptoms (10–12). The pediatricians employed at the research unit acted as primary 
practitioners for the cohort children and were the only ones responsible for the 
diagnosis and treatment of asthma, allergy, and eczema in these children.  
The study was conducted in accordance with the Declaration of Helsinki and was 
approved by the Local Ethics Committee (KF 01-289/96), and the Danish Data 
Protection Agency (2008-41-1754). Both parents gave oral and written informed 
consent before enrolment. 
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Inflammatory Biomarkers 
At age 6 months and 7 years, venous blood was sampled, centrifuged to separate plasma 
from plasma cells, and immediately stored at -80°C until analysis. The samples were 
transported on dry ice to the laboratory, where levels of inflammatory biomarkers were 
determined by high-sensitivity ELISA assays based on electro-chemiluminescence in a 4-
plex setting for IL-1β, IL-6, CXCL8 and TNF-α and as a single high-sensitivity assay from 
MesoScale Discovery for hs-CRP. The LLOD was 0.005 ng/mL. Samples were read in 
duplicates with the Sector Imager 6000 (MesoScale Discovery®, Gaithersburg, MD, 
USA). The limit of detection (mean signal from blanks +3SD) was 9.54 pg/mL for hs-CRP, 
0.15 pg/mL for IL-1β, 0.17 pg/mL for IL-6, 0.09 pg/mL for CXCL8 and 0.08 pg/mL for 
TNF-α. 
We chose to investigate hs-CRP as this is a well-established measure of non-specific low-
grade inflammation in previous NCD studies (3). The additional biomarkers were chosen to 
enable a biological validation of the hs-CRP levels, i.e. IL-6 triggers CRP release from the 
liver and should be associated with CRP whereas CXCL8 is not directly related to CRP 
release.   
Allergic Sensitization 
Allergic sensitization was assessed longitudinally at ages 6 months, 18 months, 4 years 
and 6 years by specific-IgE levels in serum and skin prick tests. 
Specific-IgE levels in serum were measured against 16 common inhalant and food 
allergens (cat, dog, horse, birch, timothy grass, mugwort, house dust mites, moulds, 
hen’s egg, cow’s milk, fish, wheat, peanut, soybean, shrimp) by ImmunoCAP assay 
(Pharmacia Diagnostics AB, Uppsala, Sweden) (13). Allergic sensitization was defined as 
specific-IgE ≥0.35kU/L (14). 
Skin prick test was performed using standard allergen extracts (ALK Abello, Soluprick® 
SQ, Hørsholm, Denmark) of 14 common allergens (cat, dog, horse, birch, timothy grass, 
mugwort, house dust mite, moulds, egg, milk, fish, wheat, peanut, soybean) and with 
fresh cow’s milk and pasteurized hen’s egg (15). Droplets of allergen extracts, fresh 
foods and controls were applied to the child’s volar forearm and a sterile lancet was 
used to prick through the droplets penetrating the skin barrier. The reaction was noted 
after 15 minutes and a positive test was defined as a wheal diameter ≥ 2 mm larger than 
the negative control (physiological sodium chloride, 9mg/mL) at ages 6 and 18 months 
and ≥ 3 mm at ages 4 and 6 years.  
Children did not use anti-histamines within 72 hours of testing, mild steroid creams 
(group 1-2) on the arms 24 hours before testing or stronger steroid creams (group 3-4) 
14 days before testing. 
Allergic sensitization diagnosed from specific-IgE or skin prick test was analyzed as 
sensitization to (1) any allergen, (2) any aeroallergen, (3) any food allergen, and (4) any 
allergen without accompanying symptoms, i.e. sensitization without asthma, rhinitis, 
food reactions or eczema.  
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Allergic Rhinitis 
Allergic rhinitis was diagnosed at age 7 years by the COPSAC pediatricians based on 
interviews with the parents on history of symptoms in the child’s 7th year of life. Rhinitis 
was defined as troublesome sneezing or blocked or runny nose in the past 12 months in 
periods without concurrent cold or flu (16,17). 
Total-IgE 
Total-IgE level was measured at age 6 years by ImmunoCAP (Pharmacia Diagnostics AB, 
Uppsala, Sweden) with a detection limit of 2 kU/l. 
Covariates 
Covariates in relation to hs-CRP levels at age 7 years included gender; tobacco smoke 
exposure (parental smoking in the home at age 7 years [yes/no]); yearly household 
income (low [<53.000 €], medium [53.000-80.000 €], high [>80.000 €]); and infections 
14 days prior to biomarker assessment (upper and lower respiratory tract infections, 
gastroenteritis or fever with unknown cause [yes/no]). Furthermore, a CRP genetic risk-
score was calculated based on 17 single nucleotide variants known to be related to CRP 
levels (18) with the score constructed as the sum of risk alleles weighted on their 
published effect size and subsequent transformed to z-scores (19). 
Statistics 
Inflammatory biomarker values below detection limit were set to half of the lowest 
value detected for the specific biomarker. Values were log-transformed, and the mean of 
the duplicate measurements were used for association analyses. Zero individuals had 
duplicate measures below LLOD. 
Associations between continuous inflammatory biomarker levels and concurrent binary 
allergy outcomes were tested by conventional statistics with logistic regression, 
whereas the association with total-IgE was analyzed by linear regression. The 
association between biomarker levels at age 6 months and subsequent development of 
allergy outcomes during preschool-age was tested by logistic generalized estimations 
equations (GEE) utilizing the repeated subject assessments at all four age-points (6 
months, 18 months, 4 years and 6 years). 
We also applied an unsupervised pattern recognition and dimensional reduction 
principal component analysis (PCA) for inflammatory biomarker levels at age 7 years. 
The PCA approach included extraction of underlying orthogonal components that 
described the systematic part of the variation across the biomarkers using centered and 
scaled mediator levels.  
All results were presented as odds ratios with 95% CI. Analyses utilizing mediator levels 
at age 7 years were adjusted for covariates associated with levels of hs-CRP using a cut-
off at p≤0.10. Analyses utilizing mediator levels at age 6 months were adjusted for 
siblings, infections 14 days prior to and wheeze at any time prior to mediator 
assessment, as we recently demonstrated an association between those covariates and 
hs-CRP at age 6 months in our cohort (20). All analyses were done using SAS version 9.3 
(SAS Institute, Cary, NC). 
Additional details are outlined in the Online Repository.  
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RESULTS 
Baseline Characteristics 
After completion of the 7-year follow-up, hs-CRP, IL-1β, IL-6, TNF-α and CXCL8 
were available for 277 (67%) of the 411 children in the cohort. Children with 
available biomarker assessments at age 7 years compared to children without 
assessments tended to come from families with higher household income (p=0.06), 
but showed no other differences in baseline characteristics or asthma, allergy or 
eczema prevalence (Table E1). Of the 277 children with mediator levels available at 
age 7 years, 214 also had levels measured at age 6 months. 
Plasma levels of hs-CRP, IL-6, TNF-α and CXCL8 were within the expected range at both 
age-points, whereas IL-1β levels were much lower than expected(21) with null values 
for 118 (43%) at age 7 years and 52 (24%) at age 6 months (Table E2). Therefore, IL-1β 
was not included in the association analyses. IL-6 and hs-CRP levels were strongly 
positively correlated (p<0.001), whereas TNF-α and CXCL8 levels were not significantly 
correlated with hs-CRP (p-values≥0.32). 
Determinants of hs-CRP at age 7 years 
Girls had significantly higher hs-CRP levels compared to boys: median hs-CRP level 4.02 
mg/L (IQR, 1.82-14.62) vs. 1.92 mg/L (0.82-6.56), p=0.0004, and hs-CRP was increased 
in children with an infectious episode within 14 days prior to biomarker assessment: 
24.19 mg/L (4.32-33.51) vs. 2.73 mg/L (1.16-7.50), p<0.0001. Household income and 
tobacco smoke exposure in the home were not associated with hs-CRP levels (Table 1). 
Based on these findings, we adjusted association analyses utilizing hs-CRP at age 7 years 
for gender and infections. 
CRP Genetic Risk-score 
The genetic CRP risk-score was linearly associated with hs-CRP levels at 6 months (β-
coefficient +0.27 per z-score increase; 95% CI, 0.13-0.41; p=0.0002) and hs-CRP levels 
at age 7 years (β-coefficient +0.24 per z-score increase; 0.03-0.44; p=0.02). Based on 
that, association analyses utilizing hs-CRP at age 6 months and 7 years were additionally 
adjusted for the genetic CRP risk-score. However, the CRP risk-score was not associated 
with the outcomes of interest, e.g. any sensitization determined by specific-IgE at age 7 
years: OR, 0.97; 95% CI, 0.76-1.24; p=0.82.   
Inflammatory Biomarkers at 7 years vs. Concurrent Allergy Endpoints 
Specific-IgE: hs-CRP was positively associated with presence of any sensitization 
(adjusted OR (aOR), 1.40; 1.14-1.72; p=0.001), aeroallergen sensitization (aOR, 1.43; 
1.15-1.77; p=0.001), and food sensitization (aOR, 1.31; 1.02-1.67; p=0.04). Elevated hs-
CRP even increased the risk of allergic sensitization among children without any clinical 
allergy manifestations (asymptomatic sensitization): aOR, 1.40; 1.06-1.85; p=0.02. 
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Skin prick test: Similarly, increasing hs-CRP level increased the risk of any sensitization 
(aOR, 1.50; 1.18-1.92; p=0.001), aeroallergen sensitization (aOR, 1.49; 1.16-1.90; 
p=0.002), food sensitization (aOR, 1.66; 1.05-2.63; p=0.03) and asymptomatic 
sensitization (aOR, 1.70; 1.07-2.70; p=0.03) diagnosed from skin prick tests. 
Allergic rhinitis: Elevated hs-CRP level was significantly associated with increased risk 
of allergic rhinitis: aOR, 1.36; 1.05-1.76; p=0.02 (Table 2). Median hs-CRP levels in 
children with and without rhinitis and the different sensitization phenotypes are 
depicted in Figure 1. 
Asthma: Level of hs-CRP was also positively associated with an increased risk of current 
asthma: aOR, 1.37; 1.03-1.84; p=0.03.  
Total-IgE: hs-CRP and total-IgE levels were positively linearly associated: adjusted β-
coefficient, 0.15; 0.03-0.26; p=0.01. 
We found no univariate associations between IL-6, TNF-α or CXCL8 levels and any of the 
above endpoints (Table 2).  
Unadjusted models revealed similar results and are shown in Table E3 Online. 
Furthermore, a sensitivity analysis excluding the 24 children with an infectious episode 
prior to the biomarker assessments showed comparable associations and significance 
levels (Table E4 Online).  
Principle Component Analysis 
An unsupervised multi-parametric PCA showed that hs-CRP, IL-6, TNF-α and CXCL8 at 
age 7 years were all positively correlated in the first principal component (PC1) 
explaining 36% of the variation in the data, whereas 27% of the variation was explained 
by PC2, which separated hs-CRP and IL-6 from TNF-α and CXCL8 (Figure 2). PC1 yielded 
increased odds ratios for all the allergic sensitization phenotypes, allergic rhinitis and 
asthma, but the association was only statistically significant for asthma (p=0.03). PC2 
was significantly associated with any positive skin prick test (p=0.02), allergic rhinitis 
(p=0.03), and showed a trend of association with several of the other phenotypes 
(Table 3). 
Inflammatory Biomarkers at 6 months vs. Development of Allergy Endpoints  
We did not detect any relationship between hs-CRP, IL-6, TNF-α or CXCL8 and 
concurrent allergic sensitization at age 6 months diagnosed from either sIgE (N=22 
cases) or skin prick test (N=21 cases). Accordingly, a Generalised Estimating Equation 
(GEE) model including sensitization data from ages 6 months, 18 months, 4 years and 6 
years did not show any associations between inflammatory biomarkers at age 6 months 
and subsequent development of sensitization against any airborne or food allergens 
during preschool age (Table E5 Online).  
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DISCUSSION 
Principle Findings 
Allergic sensitization at school age is characterized by elevated hs-CRP level 
independently of allergen type or concurrent clinical allergy manifestations suggesting 
the presence of an active systemic inflammatory process in allergic sensitization similar 
to other NCDs. 
Strengths and Limitations of the Study   
A major strength of this study is the comprehensive standardized objective assessments 
and clinical diagnoses performed solely by the research pediatricians at our single-
center site in rigorous accordance with predefined algorithms. This approach allowed 
analyses of symptomatic and asymptomatic sensitization as well as analyses of different 
sensitization phenotypes.  
Consistent results across traditionally defined sensitization phenotypes and 
symptomatic vs. non-symptomatic disease enhance the confidence in the findings. 
Associations were most prominent for hs-CRP obtained by both conventional statistics 
and by the PCA approach, where PC2 associated with sensitization and separated hs-CRP 
and IL-6 from TNF-α and CXCL8. 
Another significant strength of the study is our ability to construct and adjust for a CRP 
genetic risk-score (18) as some loci affects both the development of asthma, 
sensitization and CRP levels (22,23). The observed relationship between CRP levels and 
allergy-related outcomes could therefore be speculated to be due to pleiotropic gene 
effects and not the low grade inflammation itself (24). Our finding of a robust and 
unchanged association between sensitization and hs-CRP after adjusting for the CRP 
genetic risk-score argues against pleiotropic gene effects being responsible for the 
association.  
In line with previous studies, we found that hs-CRP was elevated in girls (25), among 
asthmatics (26) and in subjects with a recent infectious episode (27), which serves as a 
biological validation of the data. Furthermore, hs-CRP levels were strongly linearly 
associated with IL-6, which is well known to trigger CRP release from the liver (28).  
It is a limitation of the study that we could not detect a biologically meaningful signal 
from IL-1β, which may be caused by a prolonged storage time and previous freeze-thaw 
cycles of the samples. IL-1β is known to be particular sensitive to freeze-thawing and 
degrades significantly over time, even at -80 oC (29). 
We did not detect an association between passive smoke exposure and CRP at age 7 
years, which could be related to a lack of an objective assessment such as urinary, 
salivary or serum cotinine or nicotine levels at this age point.   
Another limitation of the study is the high-risk nature of the cohort, as all the children 
are born to mothers with a history of asthma, which reduces generalizability of the 
findings. However, even though the high-risk of sensitization in the cohort may have 
influenced the measured biomarker levels, this should not diminish our ability to 
explore the association between allergic sensitization and biomarker levels within the 
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cohort.  
Interpretation of the Findings 
This study shows an association between increasing levels of hs-CRP and allergic 
sensitization in 7-year-old children suggesting that the propensity to develop elevated 
levels of specific-IgE antibodies is a systemic low-grade inflammatory disorder. 
Elevated hs-CRP was present in children with allergic sensitization irrespective of 
allergen type or combination of specific sensitizations and thus not a specific 
characteristic of food or aeroallergen sensitization. This implies that low-grade 
inflammation in children with allergic sensitization is a common host feature rather 
than a disease specific trait. Such interpretation is supported by the association between 
hs-CRP and specific-IgE levels even in asymptomatic children and the association with 
total-IgE suggesting that low-grade inflammation may characterize children with poor 
immune regulation rather than children with symptomatic vs. asymptomatic disease. 
Unfortunately, the lack of association between low-grade inflammation at age 6 months 
and subsequent development of sensitization implies that hs-CRP cannot be utilized as a 
predictive biomarker.  
In line with our findings, specific-IgE data from 2-19 year-old children and adolescents 
(N=4,111) participating in the US National Health and Nutrition Examination Survey 2005-
2006 (NHANES) showed elevated hs-CRP in subjects with allergic sensitization (30). In 
contrast, another study of 131 children aged 6-18 years did not detect such association, but all 
the children had current asthma and were recruited from a tertiary pulmonary center (31), 
which may have impacted the analyses. The European multinational PASTURE (Protection 
against Allergy Study in Rural Environments) study group reported an inverse association 
between hs-CRP at age 1 year and allergic sensitization at age 4½ years among 636 children 
(32). We could not detect an association between hs-CRP levels at age 6 months and 
subsequent development of sensitization during preschool age, but comparability between our 
and the PASTURE study findings is limited as half of the population in the PASTURE study 
is from farming environments, which may affect both the level of low-grade inflammation 
and risk of sensitization. Besides these three studies, we are not aware of additional analyses 
of the interrelationship between hs-CRP and allergic phenotypes. 
The observed association between hs-CRP and sensitization may be interpreted as 
allergic sensitization being a systemic inflammatory disorder rather than an isolated T-
helper 2-driven immune response. In support of this theory, cytokines and chemokines 
originating from the allergic cascade have been shown to trigger recruitment of 
inflammatory progenitor cells from the bone marrow as a possible systemic immune-
inflammatory pathway (33). Local production of IL-6 and TNF-α triggering CRP release 
from the liver or possibly IL-1β-related inflammasome activation in tissue macrophages 
could also contribute to sustained elevation of CRP and low-grade inflammation, as CRP 
is not cleared by binding to phosphocholine on microbes in the absence of an infection. 
Alternatively, systemic low-grade inflammation is not per se part of the allergic 
sensitization immune phenotype, but is indirectly linked to sensitization through shared 
environmental risk factors such as alterations of the human microbiome (34,35) and 
changing dietary habits (36).  
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A vicious cycle of sustained low-grade inflammation with elevated hs-CRP has now been 
demonstrated in NCDs emerging from virtually all organ systems (1) proposing an 
active inflammatory process as a common nominator of such disorders. This suggests a 
central role of the immune system not only in childhood allergic sensitization, but also 
in many other idiopathic immuno-inflammatory disorders which have increased in 
prevalence along with the global adaption of modern environmental and lifestyle 
changes (37). Strategies to restore the early life immunological health status such as 
high-dose vitamin D supplementation during pregnancy (38), may thus not only have 
the capacity to prevent development of allergic sensitization but potentially also prevent 
a range of other frequent NCDs warranting increased awareness of childhood allergy in 
future NCD research. 
Conclusion 
Allergic sensitization in school-aged children of the Danish COPSAC2000 at-risk birth 
cohort is associated with elevated hs-CRP suggesting systemic low-grade inflammation 
as a phenotypic characteristic of childhood sensitization. 
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FIGURE LEGENDS 
Figure 1: hs-CRP at age 7 years and concurrent allergy endpoints 
Individual hs-CRP levels in children with (red) and without (blue) allergic sensitization 
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phenotypes. Asymptomatic sensitization is sensitization without rhinitis, food reactions, 
asthma or eczema. Horisontal lines represent median values.  
*p<0.05; **p<0.01; sIgE=specific-IgE; SPT=skin prick test. 
Figure 2: Principal component analysis of low-grade inflammatory biomarkers at 
age 7 years 
Principal component analysis biplot showing the children’s individual scores (grey dots) 
in the first principal component (PC1) and second principal component (PC2) as well as 
biomarker loadings for hs-CRP, IL-6, TNF-α and CXCL8 (red dots) and the correlation 
with allergy outcomes (blue dots). Percentages in parenthesis are the part of the total 
variation in the data set explained by the components. 
sIgE=Specific-IgE; SPT=Skin prick test 
 
TABLES 
Table 1: Baseline characteristics 
Child gender, household income, tobacco smoke exposure in the home, and recent 
infections in relation to hs-CRP level at age 7 years. 
 hs-CRP (mg/L) at age 7 
years 
CHARACTERISTIC N 
(cases/total)
Median (IQR) P-value 
Gender Male 140/277 1.92 (0.82-6.56) 0.0004 
Female 137/277 4.02 (1.82-
14.62) 
Household income (yearly)* Low 51/266 3.50 (1.63-8.74) 0.55 
Average 51/266 3.67 (1.03-
18.37) 
High 164/266 2.86 (1.21-7.50) 
Smoke exposure in the 
home 
Yes 96/271 3.10 (1.50-
12.96) 
0.15 
No 175/271 2.73 (1.05-7.55) 
Infection 14 days before hs-
CRP assessment** 
Yes 24/277 24.19 (4.32-
33.51) 
<0.0001 
 
No 253/277 2.73 (1.16-7.50) 
*Yearly household income: low (<53.000 €), medium (53.000-80.000 €), high (>80.000 
€). 
**Infections include any upper or lower respiratory tract infection, gastroenteritis or 
fever with unknown cause within 14 days before the blood sampling for hs-CRP 
measurement. 
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Table 2: Inflammatory biomarkers at age 7 years vs. allergy-associated end-points  
Association analyses between markers of low-grade inflammation (hs-CRP, IL-6, TNF-α, 
CXCL8) and concurrent allergic sensitization phenotypes. Analyses are adjusted for 
gender, infections 14 days prior to biomarker assessment and CRP genetic risk-score.   
Outcome 
(cases/total) 
Log-hs-CRP Log-IL-6 Log-TNF-α Log-CXCL8 
OR 
(95% 
CI) 
p OR 
(95% 
CI) 
p OR 
(95% 
CI) 
p OR 
(95% 
CI) 
p 
Any sensitization 
   sIgE (80/260) 1.40 
(1.14-
1.72) 
 
0.001 1.09 
(0.78-
1.53) 
0.62 1.70 
(0.80-
3.65) 
0.17 1.18 
(0.80-
1.74) 
0.41 
   Skin prick test 
(43/244) 
1.50 
(1.18-
1.92) 
 
0.001 1.19 
(0.77-
1.83) 
0.44 2.84 
(0.82-
9.88) 
0.10 1.07 
(0.60-
1.92) 
0.82 
Aeroallergen sensitization 
 
   sIgE (68/239) 1.43 
(1.15-
1.77) 
0.001 1.02 
(0.71-
1.48) 
0.91 2.43 
(0.87-
6.83) 
0.09 1.13 
(0.74-
1.72) 
0.57 
   Skin prick test 
(41/244) 
1.49 
(1.16-
1.90) 
0.002 1.16 
(0.75-
1.80) 
0.51 2.72 
(0.77-
9.63) 
0.12 1.08 
(0.60-
1.95) 
0.81 
Food sensitization 
 
   sIgE (48/219) 1.31 
(1.02-
1.67) 
0.04 1.11 
(0.71-
1.73) 
0.65 1.23 
(0.54-
2.80) 
0.62 1.25 
(0.76-
2.07) 
0.38 
   Skin prick test 
(8/244) 
1.66 
(1.05-
2.63)  
0.03 1.40 
(0.54-
3.64) 
0.49 0.73 
(0.05-
10.68) 
0.82 1.52 
(0.47-
4.93) 
0.49 
Asymptomatic sensitization1 
 
   sIgE (34/260) 1.40 
(1.06-
1.85) 
0.02 0.87 
(0.52-
1.48) 
0.51 1.20 
(0.46-
3.10) 
0.71 1.18 
(0.66-
2.07) 
0.59 
   Skin prick test 
(8/244) 
1.70 
(1.07-
2.70) 
0.03 0.91 
(0.30-
2.81) 
0.87 3.48 
(0.24-
51.31) 
0.36 0.37 
(0.06-
2.25) 
0.28 
Allergic rhinitis 
(34/256) 
1.36 
(1.05-
1.76) 
0.02 1.56 
(0.97-
2.53) 
0.07 1.62 
(0.56-
4.70) 
0.37 1.05 
(0.62-
1.78) 
0.86 
Asthma  1.37 
(1.03-
1.84) 
0.03 1.25 
(0.70-
2.22) 
0.46 1.97 
(0.53-
7.36) 
0.31 1-68 
(0.81-
3.50) 
0.16 
log-Total-IgE2 0.15 
(0.03-
0.26) 
0.01 0.13 
(-0.08–
0.33) 
0.23 0.13 
(-0.26–
0.52) 
0.52 0.01 
(-0.22–
0.24) 
0.94 
1Asymptomatic sensitization is any sensitization without concurrent rhinitis, clinical 
food reaction, asthma or eczema. 
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2Linear model. Estimate is β-coefficient (95% CI). 
 
Table 3: Principle component analysis of allergy-associated end-points at age 7 
years 
Principle component association analysis between first principle component (PC1), 
second principle component (PC2), and allergic sensitization phenotypes. 
 PC1 PC2 
OR (95% CI) p OR (95% CI) p 
Any sensitization 
   sIge  1.22 
(0.97-1.54) 
0.10 1.24 
(0.96-1.60) 
0.09 
   Skin prick test  1.28 
(0.94-1.74) 
0.12 1.41 
(1.04-1.92) 
0.03 
Aeroallergen sensitization 
   sIgE  1.20 
(0.93-1.56) 
0.17 1.28 
(0.97-1.69) 
0.08 
   Skin prick test  1.25 
(0.92-1.72) 
0.16 1.33 
(0.97-1.82) 
0.07 
Food sensitization 
   sIgE  1.18 
(0.88-1.59) 
0.17 1.25 
(0.90-1.74) 
0.18 
   Skin prick test  1.37 
(0.73-2.58) 
0.32 1.72 
(0.97-3.05) 
0.06 
Asymptomatic sensitization 
   sIgE  1.12 
(0.78-1.61) 
0.11 1.26 
(0.87-1.81) 
0.22 
   Skin prick test  1.02 
(0.51-2.03) 
0.97 1.62 
(0.87-2.99) 
0.13 
Allergic rhinitis  
 
1.30 
(0.93-1.81) 
0.12 1.49 
(1.06-2.09) 
0.02 
Asthma 1.60 
(1.04-2.45) 
0.03 1.26 
(0.85-1.87) 
0.24 
log-Total-IgE1 0.05
(-0.11–0.20)
0.55 0.14 
(-0.02–0.30) 
0.08 
1Linear model. Estimate is β-coefficient (95% CI). 
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